Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120 Authors: Chetan C. Oturkar, Nishant Gandhi, Pramod Rao, Kevin H. Eng, Austin Miller, Prashant K. Singh, Emese Zsiros, Kunle O. Odunsi, Gokul M. Das Published: 2026 Update to Figure In Figure 2 [1], the information on ERβ2 and FOXM1 expression in Figure 2H for OVCAR3 cells overlapped with the data presented in Figure 2I. In addition, the ERβ2 panel in Figure 2H for OVCAR3 cells was inadvertently flipped vertically. This error was overlooked in the original figure legend. The corrected legend appears below following deletion of the left OVCAR3 panel in Figure 2H. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. Corrected Figure 2: